Professor
1631 Hale Hollow Road
Bridgewater Corners, VT 05035
802-774-8195
ssgidding@geisinger.edu
Samuel S. Gidding, MD
Research interests
Pediatric preventive cardiology, hypercholesterolemia, hypertension, advocacy, implementation science.Education
University of California, Berkeley, 1973
BA, Trinity College, Hartford, CT, Mathematics, 1974
MD, College of Medicine and Dentistry of New Jersey, 1978
Residency, State University of New York - Upstate Pediatrics Fellowship, CS Mott Children's Hospital, Ann Arbor, MI, Pediatric Cardiology
Current research projects
IMPACTFH (Amy Sturm, Laney Jones) CAREFH (Laney Jones, Marc Williams); RISK FH (Matt Oetgens, Laney Jones); Type 1 Diabetes Screening (Laney Jones); mentees: Matt Oetgens, Eric Carruth
Grants
TODAY: a clinical trial of 3 treatments for type 2 diabetes presenting in adolescence with longitudinal follow up for 10 years.
CARDIA: an epidemiologic study of cardiovascular risk development in young adults beginning at age 18-30 years of life and with over 35 years of follow up data.
Recent publications
Gidding SS, Colangelo LA, Nwabuo CC, Lewis CE, Jacobs DR, Schreiner PJ, Lima JAC, Allen NB. PDAY risk score predicts cardiovascular events in young adults: the CARDIA study. Eur Heart J. 2022 Feb 9:ehac009. doi: 10.1093/eurheartj/ehac009. Epub ahead of 218.
TODAY Study Group, Bjornstad P, Drews KL, Caprio S, Gubitosi-Klug R, Nathan DM, Tesfaldet B, Tryggestad J, White NH, Zeitler P. Long-Term Complications in Youth-Onset Type 2 Diabetes. N Engl J Med. 2021 Jul 29;385(5):416-426. doi: 10.1056/NEJMoa2100165. PMID: 345.
Gidding SS, Wiegman A, Groselj U, Freiberger T, Peretti N, Dharmayat KI, Daccord M, Bedlington N, Sikonja J, Ray KK, Santos RD, Halle M, Tokgözoğlu L, Gutiérrez-Ibarluzea I, Pinto FJ, Geanta M. PAEDIATRIC FAMILIAL HYPERCHOLESTEROLAEMIA SCREENING IN EUROPE - PUBLIC POLICY BACKGROUND AND RECOMMENDATIONS. Eur J Prev Cardiol. 2022 Sep 5:zwac200. doi: 10.1093/eurjpc/zwac200. Epub ahead of print. PMID: 36059237.4320286.print. PMID: 35139198